查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1424471

高活性疗效原料药（HPAPI）市场：依分子类型、依生产技术、依应用、按地区

High Potency Active Pharmaceutical Ingredients Market, By Molecule Type, By Production Technology, By Application, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格
简介目录

高活性疗效原料药（HPAPI）的全球市场规模预计将从 2023 年的 278 亿美元增至 2030 年的 549.9 亿美元，预测期内复合年增长率为 10.2%。

报告范围 报告详情
基准年 2022年 2023/2024年市场规模 278亿美元
实际资料 2018-2021 预测期 2023-2030
预测期间 2023/2024 至 2030/2031 年复合年增长率： 10.20% 2030/2031价值预测 549.9亿美元
图 1. 2023 年高活性药物成分的全球市场占有率（按地区划分）
高效活性药物成分市场-IMG1

全球高活性疗效原料药（HPAPI）市场由专门生产高活性药品的製药业的重要部分组成。这些成分的特点是能够在低浓度下发挥治疗作用，并且能够精确靶向特定的疾病细胞。由于其功效和作用高活性疗效原料药(HPAPI) 越来越多地被用于治疗慢性和复杂的健康状况，例如癌症、糖尿病和自体免疫疾病。随着这些疾病在全球的盛行率持续上升，对高活性药物的需求也在增加，推动全球高活性疗效原料药（HPAPI）市场向前发展。该领域的製造商正在大力投资研发 (R&D)，以开发具有更高安全性和功效的新型 HPAPI。这个市场受到严格监管，需要严格的遏制措施和专门的设施来处理这些强效物质，这些物质在一定程度的暴露下可能有毒，导致营运成为一个主要问题。此外，药物技术的进步和创新促进了标靶治疗方法的发展，例如抗体药物复合体（ADC），其中高活性疗效原料药（HPAPI）与单株抗体偶联以结合活性药物。化合物。直接递送至癌细胞。这种精确度透过减少对健康细胞的损害并最大限度地减少副作用来改善患者的治疗结果。全球高活性疗效原料药（HPAPI）市场是一个充满活力且不断发展的领域，在有效管理复杂病理具有巨大潜力。随着持续的开发投资、强有力的法律规范以及个人化医疗的进步，HPAPI 在医疗保健领域的作用预计在不久的将来将显着扩大。

市场动态：

全球高活性疗效原料药（HPAPI）市场的成长是由对生技药品和标靶治疗的需求不断增长所推动的。癌症等慢性疾病的盛行率不断上升，推动了对具有更高效力和特异性的生技药品的需求。对罕见疾病孤儿药开发的日益关注正在推动测试活动。预计这将对全球高活性疗效原料药（HPAPI）市场产生正面影响。

本研究的主要特点

  • 本报告对全球高活性疗效原料药（HPAPI）市场进行了详细分析，并列出了以2023年为基准年的预测期（2023-2030年）的市场规模和復合年增长率。
  • 它确定了各个细分市场的潜在收益成长机会，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
  • 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球高活性疗效原料药(HPAPI) 市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
  • 全球高活性疗效原料药(HPAPI) 市场报告迎合了该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球高活性疗效原料药（HPAPI）市场的各种策略矩阵，将有助于相关人员做出决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
  • 癌症和其他慢性疾病的发生率上升
    • 抑制因素
  • 生产成本高
    • 机会
  • 增加特种药品产量
  • 主要亮点
  • 监管场景
  • 最近的趋势
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 合併、收购和合作

第四章全球高活性疗效原料药(HPAPI) 市场 - 冠状病毒 (COVID-19) 大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章全球高活性疗效原料药（HPAPI）市场，依分子类型，2018-2030

  • 新药
  • 非专利的

第六章 全球高活性疗效原料药(HPAPI) 市场（按生产技术）2018-2030 年

  • 化学合成
  • 生物技术

第七章2018-2030 年全球高活性疗效原料药(HPAPI) 市场（依应用）

  • 瘤
  • 荷尔蒙
  • 青光眼
  • 其他的

第八章全球高活性疗效原料药（HPAPI）市场，按地区，2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 南非
  • 中部非洲
  • 北非

第9章 竞争形势

  • 公司简介
    • Lonza
    • Novartis International AG
    • BASF AG
    • SEQENS
    • Carbogen Amcis AG
    • Eli Lilly and Company
    • Teva Pharmaceutical Industries Ltd
    • Bristol-Myers Squibb
    • Pfizer Inc.
    • Roche Diagnostics
    • Boehringer Ingelheim
    • Merck &Co
    • Bayer AG
    • Ajinomoto Bio-Pharma Services
    • Cambrex Corporation
    • Minakem
    • Sanofi Aventis

第10章

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI1336

Global high potency active pharmaceutical ingredients market size is expected to reach US$ 54.99 Bn by 2030, from US$ 27.80 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 10.2% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023/2024: US$ 27.80 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR: 10.20% 2030/2031 Value Projection: US$ 54.99 Bn
Figure 1. Global High Potency Active Pharmaceutical Ingredients Market Share (%), By Region, 2023
High Potency Active Pharmaceutical Ingredients Market - IMG1

Global high potency active pharmaceutical ingredients (HPAPI) market comprises of a significant segment of the pharmaceutical industry that specializes in the production of highly potent drugs. These ingredients are characterized by their ability to deliver therapeutic effects at low concentrations and their potential to target specific disease cells with precision. High potency active pharmaceutical ingredients (HPAPIs) are increasingly utilized in the treatment of chronic and complicated health conditions such as cancer, diabetes, and autoimmune diseases due to their effectiveness and specificity in action. As the prevalence of these diseases continues to rise globally, so does the demand for high potency medication, propelling the global high potency active pharmaceutical ingredients (HPAPI) market forward. Manufacturers in this sector are investing heavily in research and development (R&D) to create new HPAPIs that offer improved safety and efficacy profiles. The highly regulated nature of this market necessitates stringent containment measures and specialized facilities to handle these potent substances, which can be toxic at certain levels of exposure, thereby presenting significant operational challenges. Moreover, the advancement in technology and innovation in pharmaceuticals is leading to the development of targeted therapy approaches like antibody-drug conjugates (ADCs), where high potency active pharmaceutical ingredients (HPAPIs) are conjugated with monoclonal antibodies to deliver the active compound directly to cancer cells. This precision reduces damage to healthy cells and minimizes side effects, thereby enhancing patient outcomes. Global high potency active pharmaceutical ingredients (HPAPI) market is a dynamic and evolving field that holds substantial promise for the effective management of complex medical conditions. With continued investment in development, strong regulatory frameworks, and the advancement of personalized medicine, its role in the healthcare sector is expected to expand significantly in the near future.

Market Dynamics:

The growth of the global high potency active pharmaceutical ingredients market is driven by the increasing demand for biologics and targeted therapies. Rising prevalence of chronic diseases like cancer is propelling the demand for biologics with higher potency and specificity. Growing focus on the development of orphan drugs for rare medical conditions is boosting trial activities. This is expected to positively impact the global high potency active pharmaceutical ingredients (HPAPI) market.

Key Features of the Study:

  • This report provides an in-depth analysis of the global high potency active pharmaceutical ingredients market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2023 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global high potency active pharmaceutical ingredients market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Lonza, Novartis International AG, BASF AG, SEQENS, Carbogen Amcis AG, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb, Pfizer Inc., Roche Diagnostics, Boehringer Ingelheim, Merck & Co, Bayer AG, Ajinomoto Bio-Pharma Services, Cambrex Corporation, Minakem, and Sanofi Aventis
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up gradation, market expansion, and marketing tactics
  • Global high potency active pharmaceutical ingredients market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global high potency active pharmaceutical ingredients market

Detailed Segmentation:

  • Global High Potency Active Pharmaceutical Ingredients Market, By Molecule Type
    • Innovative
    • Generic
  • Global High Potency Active Pharmaceutical Ingredients Market, By Production Technology
    • Chemical Synthesis
    • Biotechnology
  • Global High Potency Active Pharmaceutical Ingredients Market, By Application
    • Oncology
    • Hormonal
    • Glaucoma
    • Others
  • Global High Potency Active Pharmaceutical Ingredients Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in the Global High Potency Active Pharmaceutical Ingredients Market
    • Lonza
    • Novartis International AG
    • BASF AG
    • SEQENS
    • Carbogen Amcis AG
    • Eli Lilly and Company
    • Teva Pharmaceutical Industries Ltd
    • Bristol-Myers Squibb
    • Pfizer Inc.
    • Roche Diagnostics
    • Boehringer Ingelheim
    • Merck & Co
    • Bayer AG
    • Ajinomoto Bio-Pharma Services
    • Cambrex Corporation
    • Minakem
    • Sanofi Aventis

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market High Potency Active Pharmaceutical Ingredients, By Molecule Type
    • Market High Potency Active Pharmaceutical Ingredients, By Production Technology
    • Market High Potency Active Pharmaceutical Ingredients, By Application
    • Market High Potency Active Pharmaceutical Ingredients, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Rising prevalence of cancer and other chronic diseases
    • Restraints
  • High cost of production
    • Opportunities
  • Increased production of specialty drugs
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global High Potency Active Pharmaceutical Ingredients Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global High Potency Active Pharmaceutical Ingredients Market, By Molecule Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Innovative
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Generic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global High Potency Active Pharmaceutical Ingredients Market, By Production Technology, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Chemical Synthesis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Biotechnology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global High Potency Active Pharmaceutical Ingredients Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Hormonal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Glaucoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global High Potency Active Pharmaceutical Ingredients Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2019 - 2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Production Technology, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Production Technology, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Production Technology, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Production Technology, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Production Technology, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Production Technology, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
  • South Africa
  • Central Africa
  • North Africa

9. Competitive Landscape

  • Company Profile
    • Lonza
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Novartis International AG
    • BASF AG
    • SEQENS
    • Carbogen Amcis AG
    • Eli Lilly and Company
    • Teva Pharmaceutical Industries Ltd
    • Bristol-Myers Squibb
    • Pfizer Inc.
    • Roche Diagnostics
    • Boehringer Ingelheim
    • Merck & Co
    • Bayer AG
    • Ajinomoto Bio-Pharma Services
    • Cambrex Corporation
    • Minakem
    • Sanofi Aventis
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us